BABA-W (09988.HK) +4.300 (+3.270%) Short selling $2.31B; Ratio 15.701% (BABA.US) senior executives made it clear at a financial report briefing that so far there have been no plans to sell Hama. Hema has had promising growth with steady expansion, and also achieved decent profit overall, which is the success of the digital new retail strategy of integrating offline and online. Related NewsCICC Forecasts ST HSI at 23,000-24,000, Eyes Themes of Stable Returns, Tech, Overseas Expansion, New ConsumptionAlibaba will be more open-minded, considering different options including the introduction of strategic investors, to allow the value of Hema’s business to be reflected in the valuation of the Alibaba Group as a whole.(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-03-14 16:25.) (Real-time Streaming US Stocks Quote; Except All OTC quotes are at least 15 minutes delayed.)